Loading...
Glioblastoma endothelium drives bevacizumab‐induced infiltrative growth via modulation of PLXDC1
Bevacizumab, a VEGF‐targeting monoclonal antibody, may trigger an infiltrative growth pattern in glioblastoma. We investigated this pattern using both a human specimen and rat models. In the human specimen, a substantial fraction of infiltrating tumor cells were located along perivascular spaces in...
Na minha lista:
| Udgivet i: | Int J Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6590500/ https://ncbi.nlm.nih.gov/pubmed/30414187 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.31983 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|